Overexpression of manganese superoxide dismutase gene changes the metastasis associated-character of the mouse fibrosarcoma, FSa-II

Oncology Reports

Volumn 4, Issue 5, 1997, Pages 937-940

  Himei, Kengo ^a   Kuroda, Masahiro ^a   St Clair, Daret K ^b   Urano, Muneyasu ^c   Yoshino, Tadashi ^a   Sakuma, Isao ^a   Akagi, Tadaatsu ^a   Asaumi, Junichi ^a   Joja, Ikuo ^a   Hiraki, Yoshio ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b UNIVERSITY OF KENTUCKY   (United States)

^c Yamanoue Hospital   (Japan)

Author keywords

Gene transfection; Iron; Malignant phenotype; Manganese superoxide dismutase; Transferrin receptor

Indexed keywords

CELL ADHESION MOLECULE; GENE PRODUCT; HERMES ANTIGEN; MANGANESE SUPEROXIDE DISMUTASE; TRANSFERRIN RECEPTOR;

ANIMAL CELL; ARTICLE; CARCINOGENICITY; CONTROLLED STUDY; ENZYME ACTIVITY; FIBROSARCOMA; GENE EXPRESSION; IRON METABOLISM; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030834168     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.4.5.937     Document Type: Article

References (38)

1. Oberley LW and Buettner GR: Role of superoxide dismutase in cancer: a review. Cancer Res 39: 1141-1149, 1979.
2. Borrello S, De Leo ME and Galeotti T: Defective gene expression of MnSOD in cancer cells. Mol Aspects Med 14: 253-258, 1993.
3. Yamanaka N and Deamer D: Superoxide dismutase activity in WI-38 cell cultures: effects of age, trypsinization and SV-40 transformation. Physiol Chem Phys Med NMR 6: 95-106, 1974.
4. Oberley LW, McCormick ML, Rivera ES and St. Clair DK: Manganese superoxide dismutase in normal and transformed human embryonic lung fibroblasts. Free Radical Biol Med 6: 379-384, 1989.
5. Marlhens F, Nicole A and Sinet PM: Lowered level of translatable messenger RNAs for manganese superoxide dismutase in human fibroblasts transformed by SV40. Biochem Biophys Res Commun 129: 300-305, 1985.
6. Bravard A, Sabatier L, Hoffschir F, Ricoul M, Luccioni C and Dutrillaux B: SOD2: a new type of tumor suppressor gene? Int J Cancer 51: 476-480, 1992.
7. St. Clair DK: Tumor suppression by manganese superoxide dismutase: a novel function of MnSOD? A commentary. Oncol Rep 3: 429-432, 1996.
8. Church SL, Grant JW, Ridnour LA, Oberley LW, Swanson PE, Meltzer PS and Trent JM: Increased manganese superoxide dismutase expression suppresses the malignant phenotype of human melanoma cells. Proc Natl Acad Sci USA 90: 3113-3117, 1993.
9. Li JJ, Oberley LW, St. Clair DK, Ridnour LA and Oberley TD: Phenotypic changes induced in human breast cancer cells by overexpression of manganese-containing superoxide dismutase. Oncogene 10: 1989-2000, 1995.
10. Urano M, Kuroda M, Reynolds R, Oberley TD and St. Clair DK: Expression of manganese superoxide dismutase reduces tumor control radiation dose: gene-radiotherapy. Cancer Res 55: 2490-2493, 1995.
11. Safford SE, Oberley TD, Urano M and St. Clair DK: Suppression of fibrosarcoma metastasis by elevated expression of manganese superoxide dismutase. Cancer Res 54: 4261-4265, 1994.
12. St. Clair DK, Oberley TD, Muse KE and St. Clair WH: Expression of manganese superoxide dismutase promotes cellular differentiation. Free Radical Biol Med 16: 275-282, 1994.
13. Ho PTC, Ishiguro K and Sartorelli AC: Regulation of transferrin receptor in myeloid and monocytic differentiation of HL-60 leukemia cells. Cancer Res 49: 1989-1995, 1989.
14. Kondo K, Noguchi M, Mukai K, Matsuno Y, Sato Y, Shimosato Y and Monden Y: Transferrin receptor expression in adenocarcinoma of the lung as a histopathologic indicator of prognosis. Chest 97: 1367-1371, 1990.
15. Zetter BR: Adhesion molecules in tumor metastasis. Semin Cancer Biol 4: 219-229, 1993.
16. Guan JL and Shalloway D: Regulation of focal adhesion-associated protein tyrosine kinase by both cellular adhesion and oncogenic transformation. Nature 358: 690-692, 1992.
17. Rosales C, O'Brien V, Kornberg L and Juliano R: Signal transduction by cell adhesion receptors. Biochim Biophys Acta 1242: 77-98, 1995.
18. Taher TE, Smit L, Griffioen AW, Schilder Tol EJ, Borst J and Pals ST: Signaling through CD44 is mediated by tyrosine kinases. Association with p561ck in T lymphocytes. J Biol Chem 271: 2863-2867, 1996.
19. Kawaguchi S, Kikuchi K, Ishii S, Takeda Y, Kobayashi S and Ueda T: VLA-4 molecules on tumor cells initiate an adhesive interaction with VCAM-1 molecules on endothelial cell surface. Jpn J Cancer Res 83: 1304-1316, 1992.
20. Xiao J, Messinger Y, Jin J, Myers DE, Bolen JB and Uckun FM: Signal transduction through the betal integrin family surface adhesion molecules VLA-4 and VLA-5 of human B-cell precursors activates CD19 receptor-associated protein-tyrosine kinases. J Biol Chem 271: 7659-7664, 1996.
21. St Pierre Y, Hugo P, Legault D, Tremblay P and Potworowski EF: Modulation of integrin-mediated intercellular adhesion during the interaction of thymocytes with stromal cells expressing VLA-4 and LFA-1 ligands. Eur J Immunol 26: 2050-2055, 1996.
22. Gunning P, Leavitt J, Muscat G, Ng S and Kedes L: A human β-actin expression vector system directs high-level accumulation of antisense transcripts. Proc Natl Acad Sci USA 84: 4831-4835, 1987.
23. Ho YS and Crapo JD: Isolation and characterization of complementary DNAs encoding human manganese-containing superoxide dismutase. FEBS Lett 229: 256-260, 1988.
24. Tucek-Szabo CL, Andjelic S, Lacy E, Elkon KB and Nikolic-Zugic J: Surface T cell Fas receptor/CD95 regulation, in vivo activation, and apotosis. Activation-induced death can occur without Fas receptor. J Immunol 156: 192-200, 1996.
25. Yan T, Oberley LW, Zhong W and St Clair DK: Manganese-containing superoxide dismutase overexpression causes phenotypic reversion in SV40-transformed human lung fibroblasts. Cancer Res 56: 2864-2871, 1996.
26. Halliwell B and Gutteridge JMC: Transition metals. In: Free Radicals in Biology and Medicine. Oxford University Press Inc. New York, pp15-19, 1989.
27. Halliwell B and Gutteridge JMC: Reaction of metal ions with hydrogen peroxide. In: Free Radicals in Biology and Medicine. Oxford University Press Inc. New York, pp33-46, 1989.
28. Weinberg ED: The role of iron in cancer. Eur J Cancer Prev 5: 19-36, 1996.
29. Fernandez-Pol JA, Hamilton PD and Klos DJ: Correlation between the loss of the transformed phenotype and an increase in superoxide dismutase activity in a revertant subclone of sarcoma virus-infected mammalian cells. Cancer Res 42: 609-617, 1982.
30. Vallis KA and Wolf CR: Relationship between the adaptive response to oxidants and stable menadione-resistance in Chinese hamster ovary cell lines. Carcinogenesis 17: 649-654, 1996.
31. Opanashuk LA and Finkelstein JN: Relationship of lead-induced proteins to stress response proteins in astroglial cells. J Neurosci Res 42: 623-632, 1995.
32. Camhi SL, Lee P and Choi AMK: The oxidative stress response. New Horiz 3: 170-182, 1995.
33. Kühn LC and Hentze MW: Coordination of cellular iron metabolism by post-transcriptional gene regulation. J Inorg Biochem 47: 183-195, 1992.
34. Stocker R: Induction of heme oxygenase as a defence against oxidative stress. Free Radical Res Commun 9: 101-112, 1990.
35. Balla J, Jacob HS, Balla G, Nath K, Eaton JW and Vercellotti GM: Endothelial-cell heme uptake from heme proteins: induction of sensitization and desensitization to oxidant damage. Proc Natl Acad Sci USA 90: 9285-9289, 1993.
36. Weiss G, Werner Felmayer G, Werner ER, Grunewald K, Wachter H and Hentze MW: Iron regulates nitric oxide synthase activity by controlling nuclear transcription. J Exp Med 180: 969-976, 1994.
37. Pantopoulos K and Hentze MW: Nitric oxide signaling to iron-regulatory protein: direct control of ferritin mRNA translation and transferrin receptor mRNA stability in transfected fibroblasts. Proc Natl Acad Sci USA 92: 1267-1271, 1995.
38. East JA and Hart IR: CD44 and its role in tumour progression and metastasis. Eur J Cancer 29: 1921-1922, 1993.